WallStreetZenWallStreetZen

NASDAQ: VIRX
Viracta Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VIRX

Based on 3 analysts offering 12 month price targets for Viracta Therapeutics Inc.
Min Forecast
$7.00+426.32%
Avg Forecast
$18.67+1,303.53%
Max Forecast
$33.00+2,381.2%

Should I buy or sell VIRX stock?

Based on 3 analysts offering ratings for Viracta Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VIRX stock forecasts and price targets.

VIRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$33.00+2,381.20%2023-05-10
RBC Capital
Top 5%
96
BuyMaintains$7.00+426.32%2023-05-09
Oppenheimer
Bottom 23%
23
BuyMaintains$16.00+1,103.01%2023-03-27

1 of 1

Forecast return on equity

Is VIRX forecast to generate an efficient return?
Company
N/A
Industry
0.07%
Market
70.69%

Forecast return on assets

Is VIRX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.1%

VIRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VIRX$1.33$18.67+1,303.53%Buy
NBRV$1.60N/AN/A
MEIP$7.70$33.00+328.57%Hold
CYBN$0.27$6.50+2,307.41%Strong Buy
PASG$0.95$10.00+951.52%Strong Buy
View Top Biotech Stocks

Viracta Therapeutics Stock Forecast FAQ

Is Viracta Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: VIRX) stock is to Buy VIRX stock.

Out of 3 analysts, 0 (0%) are recommending VIRX as a Strong Buy, 3 (100%) are recommending VIRX as a Buy, 0 (0%) are recommending VIRX as a Hold, 0 (0%) are recommending VIRX as a Sell, and 0 (0%) are recommending VIRX as a Strong Sell.

If you're new to stock investing, here's how to buy Viracta Therapeutics stock.

What is VIRX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: VIRX) forecast ROE is N/A, which is considered weak.

What is VIRX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year VIRX price target, the average VIRX price target is $18.67, with the highest VIRX stock price forecast at $33.00 and the lowest VIRX stock price forecast at $7.00.

On average, Wall Street analysts predict that Viracta Therapeutics's share price could reach $18.67 by May 10, 2024. The average Viracta Therapeutics stock price prediction forecasts a potential upside of 1,303.53% from the current VIRX share price of $1.33.

What is VIRX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: VIRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.